This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

KEYTRUDA® (pembrolizumab) monotherapy for HNSCC: Adverse events summary leaflet

Prescribing Information

This resource is to be used by HCPs whom are already familiar with the full KEYTRUDA® (pembrolizumab) SmPC, as a memory aid to support adverse event discussions with patients. This leaflet must always be used in conjunction with the full KEYTRUDA SmPC and not alone.

Click the button above to access the downloadable PDF leaflet 'KEYTRUDA® (pembrolizumab) monotherapy in HNSCC: A summary of adverse events of special interest and treatment modifications for use alongside SmPC'

More information about KEYTRUDA® (pembrolizumab):

Supporting documentation

GB-OHN-00170 | Date of Preparation: July 2020